Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
5 we » _ we (Expand Search), 5 wt (Expand Search), 5 w (Expand Search)
Showing 921 - 940 results of 59,271 for search '(( 5 we decrease ) OR ( 5 ((point decrease) OR (((nn decrease) OR (mean decrease)))) ))', query time: 0.93s Refine Results
  1. 921
    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.

    Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 922
    Baseline patient characteristics across neutralizing monoclonal antibody trials.

    Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 923
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 924
    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis).

    Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 925
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 926
    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies.

    Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 927
    Study Flow Diagram.

    Study Flow Diagram. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 928
    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.

    Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 929
    Type and duration of leisure-time activities performed 5 years after RYGB.

    Type and duration of leisure-time activities performed 5 years after RYGB. by Alice Bellicha (3583493)

    Published 2022
    Save to List
    Saved in:
  10. 930
    Effect sizes (posterior estimates) for the best-fit models testing the response of detection rate in vegetation types or different trajectories over time within vegetation types (see S4 Table in S1 File for model selection results and S5 Table in S1 File for posterior model estimates tables).

    Effect sizes (posterior estimates) for the best-fit models testing the response of detection rate in vegetation types or different trajectories over time within vegetation types (s... by Maldwyn John Evans (17061173)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 931
    Blocking C5L2 decreased C5a-primed neutrophils for ANCA-induced respiratory burst.

    Blocking C5L2 decreased C5a-primed neutrophils for ANCA-induced respiratory burst. by Jian Hao (160736)

    Published 2013
    Save to List
    Saved in:
  12. 932
    AA-deficient <i>sfx</i> mice had decreased articular cartilage.

    AA-deficient <i>sfx</i> mice had decreased articular cartilage. by Richard C. Lindsey (7148168)

    Published 2019
    Save to List
    Saved in:
  13. 933
    Mitochondrial dysfunction is driven by decreased mitochondrial dynamics.

    Mitochondrial dysfunction is driven by decreased mitochondrial dynamics. by Piero Dalle Pezze (622889)

    Published 2014
    “…These perturbations affected the new mitochondria only at early time points (<10 days), whereas the old mitochondria were affected throughout the time course. …”
    Save to List
    Saved in:
  14. 934
    Fig 3 Data.

    Fig 3 Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 935
    S2 Fig Data.

    S2 Fig Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 936
    Fig 2D–2F Data.

    Fig 2D–2F Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 937
    Fig 6 Data.

    Fig 6 Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 938
    Fig 1 Data.

    Fig 1 Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 939
    Fig 2A–2C and 2G–2L Data.

    Fig 2A–2C and 2G–2L Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 940
    Fig 4 Data.

    Fig 4 Data. by Kevin D. Gaitonde (15411707)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: